Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indoco Remedies Ltd. Capital/Financing Update 2023

Feb 2, 2023

62453_rns_2023-02-02_913a81a9-8d98-44cd-b365-0c4c853dfe22.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [199 x 70] intentionally omitted <==

February 2, 2023

To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO-EQ

Dear Sir/Madam,

Sub: : Intimation of Schedule of Investor Call/ Institutional Investors Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing schedule for the Investor Call/ Institutional Investors Conference/Meetings. The details of the same are as follows;

Date Particulars Type of Meeting Location
13thFebruary 2023 Institutional InvestorsCall–InvestorConference organisedbyNirmal Bang Group Virtual
17thFebruary 2023 DART India Small /Mid Cap Conference –‘TheNextMulti-billions’ - Conferenceorganised by DolatCapital Market PrivateLimited 1*1 / Small Group Virtual

Thanking you, Yours faithfully, For Indoco Remedies Limited

RAMANATH Digitally signed by RAMANATHAN AN HARIHARAN Date: 2023.02.02 HARIHARAN 09:21:45 +05'30' Ramanathan Hariharan Company Secretary & Head-Legal

==> picture [516 x 64] intentionally omitted <==